Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

NFE2L3 anticorps (C-Term)

L’anticorps Lapin Polyclonal anti-NFE2L3 a été validé pour WB. Il convient pour détecter NFE2L3 dans des échantillons de Humain. Il y a 3+ publications disponibles.
N° du produit ABIN1881578

Aperçu rapide pour NFE2L3 anticorps (C-Term) (ABIN1881578)

Antigène

Voir toutes NFE2L3 Anticorps
NFE2L3 (Nuclear Factor (erythroid-Derived 2)-Like 3 (NFE2L3))

Reactivité

  • 25
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 26
Lapin

Clonalité

  • 26
Polyclonal

Conjugué

  • 11
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp NFE2L3 est non-conjugé

Application

  • 16
  • 14
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB)

Clone

RB41576
  • Épitope

    • 7
    • 5
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 666-694, C-Term

    Purification

    This antibody is purified through a protein A column, followed by peptide affinity purification.

    Immunogène

    This NFE2L3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 666-694 amino acids from the C-terminal region of human NFE2L3.

    Isotype

    Ig Fraction
  • Indications d'application

    WB: 1:1000. WB: 1:1000

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Date de péremption

    6 months
  • Bailey, Xie, Do, Montpetit, Diaz, Mohan, Keavney, Yusuf, Gerstein, Engert, Anand: "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." dans: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, (2010) (PubMed).

    Zhang, Kobayashi, Yamamoto, Hayes: "The Nrf3 transcription factor is a membrane-bound glycoprotein targeted to the endoplasmic reticulum through its N-terminal homology box 1 sequence." dans: The Journal of biological chemistry, Vol. 284, Issue 5, pp. 3195-210, (2009) (PubMed).

    Talmud, Drenos, Shah, Shah, Palmen, Verzilli, Gaunt, Pallas, Lovering, Li, Casas, Sofat, Kumari, Rodriguez, Johnson, Newhouse, Dominiczak, Samani, Caulfield, Sever, Stanton, Shields, Padmanabhan et al.: "Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. ..." dans: American journal of human genetics, Vol. 85, Issue 5, pp. 628-42, (2009) (PubMed).

  • Antigène

    NFE2L3 (Nuclear Factor (erythroid-Derived 2)-Like 3 (NFE2L3))

    Autre désignation

    NFE2L3

    Sujet

    This gene encodes a member of the cap 'n' collar basic-region leucine zipper family of transcription factors. The encoded protein heterodimerizes with small musculoaponeurotic fibrosarcoma factors to bind antioxidant response elements in target genes. This protein is a membrane bound glycoprotein that is targeted to the endoplasmic reticulum and the nuclear envelope. Pseudogenes of this gene are found on chromosomes 16, 17, and 18.

    Poids moléculaire

    76154

    NCBI Accession

    NP_004280

    UniProt

    Q9Y4A8
Vous êtes ici:
Chat with us!